-+ 0.00%
-+ 0.00%
-+ 0.00%

Entero Therapeutics Q1 GAAP EPS $(0.28) Down From $0.38 YoY

Benzinga·05/15/2025 22:02:17
Listen to the news
Entero Therapeutics (NASDAQ:ENTO) reported quarterly losses of $(0.28) per share. This is a 173.68 percent decrease over earnings of $0.38 per share from the same period last year.